Influenza continues to pose a significant global threat, with seasonal outbreaks causing millions of infections, countless hospitalizations, economic disruptions, and approximately 290,000 to 650,000 annual deaths worldwide. Traditional flu vaccines, while criticalRead More…
Advancing Vaccine Analytical Development & Qualification: Bridging Innovation with Rigor
Vaccines have transformed modern medicine, yet their impact hinges on a behind-the-scenes hero: analytical development. This process ensures every dose meets strict safety and efficacy benchmarks, from early design to global distribution.Read More…
The Science of Inactivated Vaccines: A Comprehensive Guide
The primary foundation of modern public health vaccination strategies depends on inactivated vaccines which have shown reliable safety records and effective protection against infectious diseases. This guide examines the scientific foundation ofRead More…
mRNA T-Cell-Inducing Antigens for the Next COVID-19 Vaccine: A Broad Perspective on mRNA-Driven T-Cell Activation
Introduction Vaccines have transformed public health, limiting infectious disease spread and saving millions of lives worldwide. mRNA vaccines, by which medical science developed a method of vaccination without losing effectiveness, have made itRead More…
2024 Report: Vaccines in Development and Future Challenges
Vaccines are the most successful public health measure ever, halting the spread of infectious diseases and slowing some of the worst disease ever seen in the vast majority of the world. AsRead More…
The mRNA Vaccines of the Future: Redesigning Immunization for Today and Beyond
mRNA vaccines are one of the best medical and immunological discoveries of the past few years. While vaccines themselves aren’t exactly new, mRNA technology flips the script on how we think about immunization.Read More…
Cell: Monkeypox mRNA Vax Packs a Bigger Punch
Researchers from the U.S. Army Medical Research Institute of Infectious Diseases and Moderna published a research paper titled “Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhumanRead More…
A Game-Changer Vaccine Delivery System in the Fight Against Tumor
The team of Professor Michael J. Mitchell of the University of Pennsylvania and Professor Drew Weissman, winner of the 2023 Nobel Prize in Physiology and Medicine, published a review paper titled “EnhancingRead More…
New Vaccine Technology Released: Dendritic Cell-Targeting VLP as mRNA Vaccine Carriers
Recently, the journal Nature Biomedical Engineering published a research paper titled “Dendritic-cell-targeting virus-like particles as latent mRNA vaccine carriers” about a new vaccine platform technology that can specifically target dendritic cells (DCs)Read More…
Cell: Groundbreaking Personalized mRNA Vaccine Targets Glioblastoma
In a first-of-its-kind human clinical trial involving four adult patients, an mRNA cancer vaccine developed by the University of Florida rapidly reprograms the immune system to attack glioblastoma, the most aggressive andRead More…